These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33738257)

  • 1. The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.
    Liu Z; Wang L; Liu L; Lu T; Jiao D; Sun Y; Han X
    Front Oncol; 2021; 11():619242. PubMed ID: 33738257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
    Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
    Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management.
    Liu Z; Liu L; Lu T; Wang L; Li Z; Jiao D; Han X
    J Oncol; 2021; 2021():6664386. PubMed ID: 33552157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
    Huo J; Cai J; Guan G; Liu H; Wu L
    Front Cell Dev Biol; 2021; 9():761839. PubMed ID: 34869350
    [No Abstract]   [Full Text] [Related]  

  • 5. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
    Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
    Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
    Front Oncol; 2021; 11():755212. PubMed ID: 34804944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an immune-related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma.
    Yang CB; Feng HX; Dai CL
    Cancer Med; 2022 Jun; 11(11):2329-2341. PubMed ID: 35092175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.
    Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G
    BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cuproptosis and ferroptosis-related subgroups and development of a signature for predicting prognosis and tumor microenvironment landscape in hepatocellular carcinoma.
    Yang BF; Ma Q; Hui Y; Gao XC; Ma DY; Li JX; Pei ZX; Huang BR
    Transl Cancer Res; 2023 Dec; 12(12):3327-3345. PubMed ID: 38192999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of colorectal carcinoma subtypes based on ferroptosis-associated molecular markers.
    Yue Q; Zhang Y; Wang F; Cao F; Duan X; Bai J
    World J Surg Oncol; 2022 Apr; 20(1):117. PubMed ID: 35410338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
    Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
    Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
    Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
    Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma.
    Liu X; Sun B; Yao Y; Lai L; Wang X; Xiong J; Zhang X; Jiang J
    Front Immunol; 2022; 13():996308. PubMed ID: 36275743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis Patterns Correlate with Immune Microenvironment Characterization in Gastric Cancer.
    Jiang X; Liu F; Liu P; Yan Y; Lan S; Zhuang K; Liu Y; Jiang K; Huang Y; Nie K; Zheng Z; Pan J; Zheng J; Liu F; Xu S; Li P; Wen Y
    Int J Gen Med; 2021; 14():6573-6586. PubMed ID: 34675624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.
    Zhu J; Xu X; Jiang M; Yang F; Mei Y; Zhang X
    Front Oncol; 2023; 13():1145380. PubMed ID: 37051544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma.
    Zhang W; Yao S; Huang H; Zhou H; Zhou H; Wei Q; Bian T; Sun H; Li X; Zhang J; Liu Y
    Oncoimmunology; 2021; 10(1):1959977. PubMed ID: 34527427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma.
    Sun L; Liu Z; Wu Z; Ning K; Hu J; Chen Z; Wu Z; Yin X
    Front Immunol; 2023; 14():1113455. PubMed ID: 37051238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma.
    Liu Z; Lu T; Wang L; Liu L; Li L; Han X
    Front Mol Biosci; 2021; 8():682084. PubMed ID: 34307451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.